- ►annals.org [PDF] SR Salpeter, TM Ormiston, EE Salpeter - Annals of internal medicine, 2004 - Am Coll Physicians Background: The regular administration of 2-agonists may be associated with the
development of tolerance to their effects. Purpose: To assess the effect of
regular 2-agonist use on respi- ratory function and 2-receptor function in ... Cited by 77 - Related articles - BL Direct - All 4 versions
D Sources, D Extraction, D Synthesis - Annals of Internal Medicine, 2004 - Am Coll Physicians Background: The regular administration of 2-agonists may be associated with the
development of tolerance to their effects. Purpose: To assess the effect of
regular 2-agonist use on respi- ratory function and 2-receptor function in ... Related articles - All 2 versions
- ►critcaremed.org SR Salpeter - Drugs &# 38; Aging, 2004 - ingentaconnect.com Background: β 2 -Adrenoceptor agonists have been used as bronchodilators in the
Abstract management of asthma and chronic obstructive pulmonary disease (COPD);
however, there is evidence suggesting that β 2 -adrenoceptor agonist use ... Cited by 37 - Related articles - BL Direct - All 5 versions
- ►nih.gov SR Salpeter, NS Buckley, EE Salpeter - Journal of General Internal Medicine, 2006 - Springer BAGRO[TND: Anticholinergics and 2-agonists have generally been considered
equivalent choices for bronchodilation in chronic obstruc- tive pulmonary
disease (COPD). OBJECTIVE; To assess the safety and efficacy of ... Cited by 96 - Related articles - BL Direct - All 12 versions
JF Donohue, S Menjoge, S Kesten - Respiratory medicine, 2003 - Elsevier Loss of bronchodilator effectiveness or tolerance has been observed with inhaled
beta-agonists but not with inhaled anticholinergic medications. Initially,
tolerance is reflected in loss of bronchial protection against stimuli ... Cited by 56 - Related articles - All 6 versions
- ►annals.org SR Salpeter, NS Buckley, TM Ormiston, EE … - Annals of internal medicine, 2006 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: Long-acting ß-agonists may increase the risk for fatal and ... Cited by 203 - Related articles - BL Direct - All 11 versions
DR Taylor, MR Sears, DW Cockcroft - Medical Clinics of North America, 1996 - Elsevier Despite widespread use of adrenergic agents in the management of asthma for many
decades, doubts have emerged concerning the safety and efficacy of long-term
inhaled beta-agonist therapy. Various strands of evidence have raised ... Cited by 49 - Related articles - All 3 versions
[CITATION] Long-acting beta-agonists increase severe asthma exacerbations and asthma-related deaths: …
